Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.

@article{White2007TransdermalSA,
  title={Transdermal scopolamine: an alternative to ondansetron and droperidol for the prevention of postoperative and postdischarge emetic symptoms.},
  author={Paul F. White and Jun Ling Tang and Dajun Song and Jayne E Coleman and Ronald H Wender and Babatunde O. Ogunnaike and Alexander Sloninsky and Rajani Kapu and Mary Shah and Tom Webb},
  journal={Anesthesia and analgesia},
  year={2007},
  volume={104 1},
  pages={92-6}
}
BACKGROUND Given the controversy regarding the use of droperidol and the high cost of the 5-HT3 antagonists, a cost-effective alternative for routine use as a prophylactic antiemetic would be desirable. We designed two parallel, randomized, double-blind sham and placebo-controlled studies to compare the early and late antiemetic efficacy and adverse event profile of transdermal scopolamine (TDS) 1.5 mg, to ondansetron 4 mg IV, and droperidol 1.25 mg IV for antiemetic prophylaxis as part of a… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…